Tag: GLP-1 drugs
Supply Trackers Introduced to Help Patients During Shortages of Popular Diabetes and Weight Loss Drugs
As Novo Nordisk and Eli Lilly grapple with the exponential demand for their widely sought-after drugs for diabetes and weight loss, the healthcare industry is[more...]
Telehealth Company Hims & Hers Disrupts Weight Loss Medication Market with Affordable GLP-1 Drugs
Direct-to-consumer pharmaceutical startup Hims & Hers Health is shaking up the weight loss medication market by introducing injectable GLP-1 drugs at a fraction of the[more...]
Senator Bernie Sanders Urges Novo Nordisk to Lower Ozempic Price Amid Firestorm of Controversy
Senator Bernie Sanders has expressed his intention to meet with Novo Nordisk A/S’s CEO to discuss the pricing of its premier drug, Ozempic, amid mounting[more...]
Possible Connection Between GLP-1 Drugs and Suicidal Thoughts: FDA Investigation Continues
The Food and Drug Administration (FDA) recently announced that it has not found compelling evidence linking GLP-1 drugs, including semaglutide, to suicidal thoughts or behaviors.[more...]
